M, F., S, S., N, S., K, H., H, Y., H, O., . . . H, S. (2013). Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations. Dove Medical Press.
Style de citation Chicago (17e éd.)M, Fukuda, Shibata S, Shibata N, Hagihara K, Yaguchi H, Osada H, Takahashi N, Kubo E, et Sasaki H. Safety Comparison of Additives in Antiglaucoma Prostaglandin (PG) Analog Ophthalmic Formulations. Dove Medical Press, 2013.
Style de citation MLA (8e éd.)M, Fukuda, et al. Safety Comparison of Additives in Antiglaucoma Prostaglandin (PG) Analog Ophthalmic Formulations. Dove Medical Press, 2013.
Attention : ces citations peuvent ne pas être correctes à 100%.